Oddity Tech Ltd. (NASDAQ:ODD) is one of the most oversold mid-cap stocks to buy according to hedge funds. On October 8, 2025, KeyBanc Capital Markets analyst Scott Schoenhaus maintained an Overweight rating on Oddity Tech but lowered the price target from $90 to$80. The firm emphasized that Oddity remains in the early innings of a high-growth story, with potential upside driven by its proprietary hyperspectral + biotech stack and the upcoming Q4 launch of a medical-grade skin and body care brand. KeyBa ...